StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Vifor Pharma said to have confirmed the purchase of Sarepta's (SRPT) Priority Review Voucher - Bloomberg
February 25, 2020 12:14 PM
Vifor Pharma said to ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
FDA
Rumors
Trader Talk
Next Articles
Sarepta Therapeutics (SRPT) Tops Q4 EPS by 29c, Revenues Beat
February 26, 2020 4:13 PM
Sarepta Therapeutics (SRPT) May Have Sold Priority Review Voucher to Vifor - RBC
February 25, 2020 11:03 AM